Quantitative Mass Spectrometry-Based Proteomics for Biomarker Development in Ovarian Cancer

Ovarian cancer is the most lethal gynecologic malignancy among women. Approximately 70–80% of patients with advanced ovarian cancer experience relapse within five years and develop platinum-resistance. The short life expectancy of patients with platinum-resistant or platinum-refractory disease under...

Descripción completa

Detalles Bibliográficos
Autores principales: Ryu, Joohyun, Thomas, Stefani N.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2021
Materias:
Review
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8125593/
https://www.ncbi.nlm.nih.gov/pubmed/34063568
http://dx.doi.org/10.3390/molecules26092674

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8125593/
https://www.ncbi.nlm.nih.gov/pubmed/34063568
http://dx.doi.org/10.3390/molecules26092674

Ejemplares similares